Pancreatic Cancer Research

ResearcherUniversity of California, San FranciscoActive in the last 2 years

Kimberly Saunders Kirkwood

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6876-2752; OpenAlex author ID A5014807498; NIH RePORTER profile ID 2087069. Sources: ClinicalTrials.gov.

Their work

Papers
11 (first author 1, last author 1)
Trials
1 (principal investigator on 1)
Grants
3
Labs led
1
Collaborators
35
Papers, trials and grants by year

2016: 2 papers, 1 grant · 2017: none · 2018: none · 2019: 1 paper, 1 trial · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 3 papers · 2025: none · 2026: 1 paper, 2 grants

Papers 11

  1. Impact of adjuvant chemotherapy among pathologic complete responders with pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejso.2026.111955↗
  2. Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer. Co-author DOI 10.1245/s10434-024-15579-0↗
  3. Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-024-15841-5↗
  4. Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC). Co-author DOI 10.3390/curroncol31090370↗
  5. Addressing the unmet clinical need for low-volume assays in early diagnosis of pancreatic cancer. Co-author DOI 10.3389/fgstr.2023.1258998↗
  6. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. Co-author DOI 10.1158/1940-6207.capr-20-0303↗
  7. Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study. Last author DOI 10.1016/j.jamcollsurg.2019.09.019↗
  8. Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-20-0268↗
  9. Comparison of Tumor Regression Grading of Residual Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Chemotherapy Without Radiation: Would Fewer Tier-Stra… Co-author DOI 10.1097/pas.0000000000001152↗
  10. Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy? Co-author DOI 10.1002/jso.24375↗
  11. Early and accurate diagnosis of pancreatic cancer? First author DOI 10.18632/oncotarget.13142↗

Trials 1

  1. UCSF PANC Cyst Registry Principal investigator NCT04291651↗

Grants 3

  1. Advancing the Clinical Translation of Cyst Fluid Assays for Early Detection of Pancreatic Cancer U01CA271250↗
  2. Using microvolumetric cyst fluid proteolysis for early detection of pancreatic cancer U01CA282269↗
  3. Non-invasive Differentiation of Benign Lesions from Aggressive Pancreatic Cancer R21CA185689↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eric K. Nakakura · 6 shared papers, 2016–2026 · strength 1.01
  2. Mohamed A. Adam · 4 shared papers, 2024–2026 · strength 0.86
  3. Adnan A. Alseidi · 4 shared papers, 2024–2026 · strength 0.86
  4. Ajay V. Maker · 3 shared papers, 2024 · strength 0.57
  5. Charles S. Craik · 1 shared paper, 1 shared grant, 2016–2023 · strength 0.43
  6. Paige M. Bracci · 1 shared paper, 1 shared trial, 2019–2020 · strength 0.42
  7. Jane Wang · 2 shared papers, 2024 · strength 0.36
  8. Jeremy M. Sharib · 3 shared papers, 2016–2020 · strength 0.33
  9. Andrew H. Ko · 3 shared papers, 2016–2024 · strength 0.33
  10. Sunhee S. Kim · 3 shared papers, 2016–2024 · strength 0.33
  11. Grace Kim · 3 shared papers, 2016–2024 · strength 0.33
  12. Margaret A. Tempero · 3 shared papers, 2016–2024 · strength 0.33
  13. Seif Elmankabadi · 1 shared paper, 2026 · strength 0.29
  14. Amir Ashraf · 1 shared paper, 2026 · strength 0.29
  15. Paul Wong · 1 shared paper, 2024 · strength 0.21
  16. Han Yin · 1 shared paper, 2024 · strength 0.18
  17. June S. Peng · 1 shared paper, 2024 · strength 0.18
  18. Daniel A. Sheik · 1 shared paper, 2023 · strength 0.18
  19. Amir Ashraf‐Ganjouei · 1 shared paper, 2024 · strength 0.18
  20. Vincent Jo Davisson · 1 shared paper, 2023 · strength 0.18
  21. Phoebe N. Miller · 1 shared paper, 2024 · strength 0.18
  22. Zhen J. Wang · 2 shared papers, 2016–2019 · strength 0.15
  23. Carrie Cao · 1 shared paper, 2020 · strength 0.12
  24. Suyu Liu · 1 shared paper, 2021 · strength 0.11
  25. Subrata Sen · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.